Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Citigroup Maintains Neutral on Bristol-Myers Squibb, Raises Price Target to $60
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Merck, AstraZeneca Report Positive Data for Koselugo in Adults
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
10 Health Care Stocks Whale Activity In Today's Session